Clinical Trial

Evaluate the Efficacy and Safety of CTO0307 in Adults With Presbyopia

Name: Evaluate the Efficacy and Safety of CTO0307 in Adults With Presbyopia — clinical trial record (NCT07723716)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

This study was to compare the presbyopia correction effect between the treatment group and the control group, evaluated by the proportion of patients who achieved an improvement of 3 lines or more in mesopic binocular DCNVA at 3 hours post-dose after 4 weeks of administration of the investigational product.

Trial Details

NCT Number	NCT07723716
Lead Sponsor	Taejoon Pharmaceutical Co., Ltd.
Conditions	Presbyopia
Enrollment	167 participants
Start Date	2025-02-26
Primary Completion	2025-09-25 (estimated)
Study Completion	2025-09-25 (estimated)
Updated on ClinicalTrials.gov	2026-08-12